CCE is approved across all of Europe, Japan, Canada, and other countries as a viable procedure for colorectal cancer screening. However, to bring it into clinical practice and make it part of the toolbox a medical professional can tap into to make the best possible diagnosis, this additional study will be conducted. The overall study comprises the trial with 250 patients as described above as well as multiple other ones that look at over 3,000 patients in a normal HD-CCE delivery, i.e. without that additional colonoscopy.
While many times before colon capsule endoscopy (CCE) has been proven to be nearly as accurate as an invasive colonoscopy, in CAREforCOLON Trial I we looked specifically at the results in a group of screening patients with a positive result and used home-delivered CCE, rather then conducting the procedure in a practice or clinic.
A patient who agreed to participate went through a standard Home-Delivered Colon Capsule Endoscopy by CorporateHealth and immediately the next day – without the need for additional cleansing – received a colonoscopy at Odense University Hospital in Nyborg. Neither the diagnostic team from CorporateHealth nor the specialists from OUH knew the outcome of the other procedure before both were completed, to avoid any bias.
After comparing the results, the patient was informed of the outcome and had an additional discussion for any follow-up if needed. Meanwhile the scientific study team analyzes the accuracy of HD-CCE over colonoscopy from all captured data.
After the first study has now been completed, more are being prepared. However, via our medical center in Hamburg and depending on your circumstances, video capsule endoscopy can be delivered today.